DISPOSITION OF ORAL METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND ITS RELATION TO 6-MERCAPTOPURINE PHARMACOKINETICS

被引：0
|
作者：
KOREN, G
SOLH, H
KLEIN, J
SOLDIN, SJ
GREENBERG, M
机构：
[1] UNIV TORONTO,HOSP SICK CHILDREN,DIV HEMATOL ONCOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA
[3] UNIV TORONTO,HOSP SICK CHILDREN,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA
[4] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
[5] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PHARMACOL,TORONTO M5G 1X8,ONTARIO,CANADA
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1989年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：450 / 454
页数：5
相关论文
共 50 条
  • [41] 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia
    Schmiegelow, K
    Bretton-Meyer, U
    LEUKEMIA, 2001, 15 (01) : 74 - 79
  • [42] METHOTREXATE AND 6-MERCAPTOPURINE MAINTENANCE THERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - DOSE ADJUSTMENTS BY WHITE CELL COUNTS OR BY PHARMACOKINETIC PARAMETERS
    SCHMIEGELOW, K
    SCHRODER, H
    SCHMIEGELOW, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (03) : 209 - 215
  • [43] PHARMACOKINETICS (PK) OF TWO 6-MERCAPTOPURINE (6-MP) LIQUID FORMULATIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL).
    Tolbert, J. A.
    Kearns, G. L.
    Abdel-Rahman, S. M.
    Weir, S. J.
    Leeder, J. S.
    Neville, K. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S94 - S94
  • [44] VARIABILITY OF 6-MERCAPTOPURINE PHARMACOKINETICS DURING ORAL-MAINTENANCE THERAPY OF CHILDREN WITH ACUTE-LEUKEMIA
    LAFOLIE, P
    BJORK, O
    HAYDER, S
    AHSTROM, L
    PETERSON, C
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1989, 6 (04): : 259 - 265
  • [45] METHOTREXATE ABSORPTION IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    CRAFT, AW
    RANKIN, A
    AHERNE, W
    CANCER TREATMENT REPORTS, 1981, 65 : 77 - 81
  • [46] INFLUENCE OF CO-TRIMOXAZOLE ON METHOTREXATE PHARMACOKINETICS IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    BEACH, BJ
    WOODS, WG
    HOWELL, SB
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1981, 3 (02): : 115 - 119
  • [47] CONGENITAL THIOPURINE METHYLTRANSFERASE DEFICIENCY AND 6-MERCAPTOPURINE TOXICITY DURING TREATMENT FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    LENNARD, L
    GIBSON, BES
    NICOLE, T
    LILLEYMAN, JS
    ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (05) : 577 - 579
  • [48] PHARMACOKINETICS OF ERYTHROCYTE METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA DURING MAINTENANCE TREATMENT
    SCHRODER, H
    CLAUSEN, N
    OSTERGAARD, E
    PRESSLER, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 16 (02) : 190 - 193
  • [49] Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy
    Ostergaard, Anna
    Bohnstedt, Cathrine
    Grell, Kathrine
    Degn, Matilda
    Zeller, Bernward
    Taskinen, Mervi
    Hafsteinsdottir, Solveig
    Bjorgvinsdottir, Helga
    Heyman, Mats
    Hoogerbrugge, Peter
    Schmiegelow, Kjeld
    LEUKEMIA, 2021, 35 (03) : 863 - 866
  • [50] Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy
    Anna Østergaard
    Cathrine Bohnstedt
    Kathrine Grell
    Matilda Degn
    Bernward Zeller
    Mervi Taskinen
    Solveig Hafsteinsdottir
    Helga Björgvinsdóttir
    Mats Heyman
    Peter Hoogerbrugge
    Kjeld Schmiegelow
    Leukemia, 2021, 35 : 863 - 866
12345